To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
AmorChem backs research on central nervous system diseases
Canadian life sciences venture capital firm AmorChem has invested in a research program from Université Laval and the Research Center of the Centre Hospitalier Universitaire de Québec.
